Meal Timing During Cancer Treatment in Alaska

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Recruiting N/A Interventional Study
Rectal Cancer Stage II Rectal Cancer Stage III Breast Cancer Stage I Rectal Cancer Stage IV Breast Cancer Stage II Breast Cancer Stage III Solid Tumor Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
100 (estimated)
Sponsor
Fred Hutchinson Cancer Center · Other
Who this trial is looking for

This trial is looking for people with breast or rectal cancer who are receiving treatment at the Alaska Native Medical Center. Participants will follow a specific meal-timing schedule to see if it helps their treatment and overall health.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 21 years or older.
  • I identify as Alaska Native or American Indian.
  • I have stage II, III, or IV rectal cancer.
  • I have stage I, II, or III HER2+ or triple-negative breast cancer.
  • I have a body mass index (BMI) of at least 18.5.
  • I plan to receive more than 3 months of treatment.
  • I can give informed consent.
  • I have completed 4 weeks or less of my treatment before enrolling.

You may not be able to join if

  • I had chemotherapy within the last 12 months.
  • I have an active second cancer that needs treatment.
  • I have had any pelvic radiation therapy in the past.
  • I have a history of severe bowel disorders.
  • I am currently pregnant or breastfeeding.
  • I have severe psychiatric or cognitive disorders.
  • I participate in overnight shift work more than once a week.
  • I am allergic to any treatment used in the trial.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to test meal-timing as a novel and sustainable interventional approach during cancer treatment to improve therapeutic response and metabolic health in an understudied population. This clinical trial will enroll patients with rectal or breast cancer receiving neoadjuvant treatment at the Alaska Native Medical Center (ANMC), which is part of the Alaska Native Triba…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female * Self-identify as Alaska Native or American Indian person and eligible for care at the ANMC * Age≥21 years * Histologically confirmed rectal cancer stage II, III, or IV (if curative) per AJCC criteria (neoadjuvant) * Histologically confirmed HER2+ or triple neg…
Contacts

Timothy Thomas, MD

(907) 729-3095

tkthomas@anthc.org

CONTACT